If lymph node involvement is tested within a patient undergoing neoadjuvant therapy who is a possible candidate for targeted axillary dissection (TAD), a marker need to be inserted during the lymph node immediately after biopsy. It is actually properly recognized that MBC within the early phase is incurable but https://brianp531jry7.bligblogging.com/profile